- Home
- MTLS vs TMCI Comparison
MTLS vs TMCI Comparison
Compare MTLS & TMCI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MTLS
- TMCI
- Stock Information
- Founded
- MTLS 1990
- TMCI 2014
- Country
- MTLS Belgium
- TMCI United States
- Employees
- MTLS N/A
- TMCI N/A
- Industry
- MTLS Computer Software: Prepackaged Software
- TMCI Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- MTLS Technology
- TMCI Health Care
- Exchange
- MTLS Nasdaq
- TMCI Nasdaq
- Market Cap
- MTLS 349.7M
- TMCI 401.8M
- IPO Year
- MTLS 2014
- TMCI 2021
- Fundamental
- Price
- MTLS $6.18
- TMCI $6.03
- Analyst Decision
- MTLS
- TMCI Hold
- Analyst Count
- MTLS 0
- TMCI 5
- Target Price
- MTLS N/A
- TMCI $8.60
- AVG Volume (30 Days)
- MTLS 146.7K
- TMCI 292.8K
- Earning Date
- MTLS 10-23-2025
- TMCI 11-04-2025
- Dividend Yield
- MTLS N/A
- TMCI N/A
- EPS Growth
- MTLS N/A
- TMCI N/A
- EPS
- MTLS 0.11
- TMCI N/A
- Revenue
- MTLS $311,850,851.00
- TMCI $213,751,000.00
- Revenue This Year
- MTLS $2.98
- TMCI $10.63
- Revenue Next Year
- MTLS $7.09
- TMCI $9.43
- P/E Ratio
- MTLS $60.22
- TMCI N/A
- Revenue Growth
- MTLS 2.98
- TMCI 7.67
- 52 Week Low
- MTLS $3.93
- TMCI $4.54
- 52 Week High
- MTLS $9.69
- TMCI $10.79
- Technical
- Relative Strength Index (RSI)
- MTLS 64.29
- TMCI 29.93
- Support Level
- MTLS $5.35
- TMCI $6.09
- Resistance Level
- MTLS $6.41
- TMCI $6.52
- Average True Range (ATR)
- MTLS 0.32
- TMCI 0.31
- MACD
- MTLS 0.09
- TMCI -0.11
- Stochastic Oscillator
- MTLS 80.59
- TMCI 0.00
About MTLS Materialise NV
Materialise NV is a provider of 3D printing services. The products and services of the group are organized in three segments: Medical segment, which develops and delivers medical software solutions, medical devices, and other related products and services; Software segment, which develops and delivers additive manufacturing software solutions and related services; and Manufacturing segment, which delivers 3D printed products and related services. Its geographical segments are the United States, the Americas (excluding the USA), Belgium, Germany, France, Switzerland, the United Kingdom, Italy, the Netherlands, Other Europe, and the Asia Pacific.
About TMCI Treace Medical Concepts Inc.
Treace Medical Concepts Inc is a commercial-stage orthopaedic medical device company. It is focused on advancing the standard of care for the surgical management of bunion deformities. The company's patented Lapiplasty 3D Bunion Correction procedure is designed to reproducibly correct all planes of the bunion deformity and address the root cause of the bunion, while allowing patients to return to their active lives quickly. The Company operates and manages its business as one segment, which is the business of designing, manufacturing, and marketing medical devices for physicians, surgeons, ambulatory surgery centers and hospitals.